Toxoplasma Seroconversion with Negative or Transient Immunoglobulin M in Pregnant Women: Myth or Reality? A French Multicenter Retrospective Study

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2013 Apr 26

PMID 23616461

Citations 27

Authors

H Fricker-Hidalgo

B Cimon

C Chemla

M L Darde

L Delhaes

C LOllivier

N Godineau

S Houze

L Paris

D Quinio

F Robert-Gangneux

O Villard

I Villena

E Candolfi

H Pelloux

Affiliations

Soon will be listed here.

Abstract

Classically, Toxoplasma infection is associated with high levels of specific IgM antibody and a rise in specific IgG levels 1 to 3 weeks later. Atypical IgG seroconversion, without IgM detection or with transient IgM levels, has been described during serologic follow-up of seronegative pregnant women and raises difficulties in interpreting the results. To evaluate the frequency and the characteristics of these atypical cases of seroconversion, an investigation was conducted within the French National Reference Center for Toxoplasmosis, from which 26 cases collected from 12 laboratories belonging to the network were identified. The aim of this work was to retrospectively analyze the results of serologic testing, the treatments administered, and the results of prenatal and postnatal follow-up for these women. In each case, IgG antibodies were detected using both screening and confirmatory tests. IgM antibodies were not detected in 15 cases, and the levels were equivocal or low-positive in 11 cases. The IgG avidity results were low in 16 cases and high in one case. Most of the pregnant women (22/26) were treated with spiramycin from the time that IgG antibodies appeared until delivery. Amniotic fluid was analyzed for Toxoplasma gondii DNA by PCR in 11/26 cases, and the results were negative in all cases. Congenital toxoplasmosis was ruled out in 12/26 newborns. There was no abnormality observed at birth for 10 newborns and no information available for 4 newborns. In conclusion, when the interpretation of serological results is so difficult, it seems cautious to initiate treatment by spiramycin and to follow the pregnant women and their newborns.

Citing Articles

Serological and molecular detection of Toxoplasma Gondii among cancer patients in Sohag, Upper Egypt: a case-control study.

Fadel E, Tolba M, Ahmed A, El-Hady H Sci Rep. 2025; 15(1):5236.

PMID: 39939648 PMC: 11822034. DOI: 10.1038/s41598-025-88680-3.

Evaluation of different cut-off points for IgG avidity and IgM in the diagnosis of acute toxoplasmosis in pregnant women participating in a congenital toxoplasmosis screening program.

Laguardia M, Carellos E, Andrade G, Carneiro M, Januario J, Vitor R Rev Inst Med Trop Sao Paulo. 2024; 66():e43.

PMID: 39082482 PMC: 11295287. DOI: 10.1590/S1678-9946202466043.

Systematic Review and Meta-Analysis of Congenital Toxoplasmosis Diagnosis: Advances and Challenges.

Franco P, Scussel A, Silva R, Araujo T, Gonzaga H, Marcon C J Trop Med. 2024; 2024:1514178.

PMID: 38419946 PMC: 10901580. DOI: 10.1155/2024/1514178.

Toxoplasma gondii Infection in Pregnancy - Recommendations of the Working Group on Obstetrics and Prenatal Medicine (AGG - Section on Maternal Disorders).

Schneider M, Faschingbauer F, Kagan K, Gross U, Enders M, Kehl S Geburtshilfe Frauenheilkd. 2023; 83(12):1431-1445.

PMID: 38046526 PMC: 10689109. DOI: 10.1055/a-2111-7394.

Detection of Infection in Small Ruminants: Old Problems, and Current Solutions.

Holec-Gasior L, Solowinska K Animals (Basel). 2023; 13(17).

PMID: 37684960 PMC: 10487074. DOI: 10.3390/ani13172696.

References

Villena I, Ancelle T, Delmas C, Garcia P, Brezin A, Thulliez P . Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill. 2010; 15(25). DOI: 10.2807/ese.15.25.19600-en. View

Calderaro A, Piccolo G, Peruzzi S, Gorrini C, Chezzi C, Dettori G . Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system. Clin Vaccine Immunol. 2008; 15(7):1076-9. PMC: 2446631. DOI: 10.1128/CVI.00025-08. View

Maubon D, Ajzenberg D, Brenier-Pinchart M, Darde M, Pelloux H . What are the respective host and parasite contributions to toxoplasmosis?. Trends Parasitol. 2008; 24(7):299-303. DOI: 10.1016/j.pt.2008.03.012. View

Pelloux H, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P . Detection of anti-Toxoplasma immunoglobulin M in pregnant women. J Clin Microbiol. 1997; 35(8):2187. PMC: 229936. DOI: 10.1128/jcm.35.8.2187-2187.1997. View

Olariu T, Remington J, McLeod R, Alam A, Montoya J . Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants. Pediatr Infect Dis J. 2011; 30(12):1056-61. DOI: 10.1097/INF.0b013e3182343096. View

Jost C, Touafek F, Fekkar A, Courtin R, Ribeiro M, Mazier D . Utility of immunoblotting for early diagnosis of toxoplasmosis seroconversion in pregnant women. Clin Vaccine Immunol. 2011; 18(11):1908-12. PMC: 3209025. DOI: 10.1128/CVI.05303-11. View

Carlier Y, Truyens C, Deloron P, Peyron F . Congenital parasitic infections: a review. Acta Trop. 2011; 121(2):55-70. DOI: 10.1016/j.actatropica.2011.10.018. View

Sensini A . Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clin Microbiol Infect. 2006; 12(6):504-12. DOI: 10.1111/j.1469-0691.2006.01444.x. View

DESMONTS G, Remington J . Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol. 1980; 11(6):562-8. PMC: 273461. DOI: 10.1128/jcm.11.6.562-568.1980. View

10.

Sterkers Y, Varlet-Marie E, Marty P, Bastien P . Diversity and evolution of methods and practices for the molecular diagnosis of congenital toxoplasmosis in France: a 4-year survey. Clin Microbiol Infect. 2009; 16(10):1594-602. DOI: 10.1111/j.1469-0691.2009.03101.x. View

11.

Maudry A, Chene G, Chatelain R, Patural H, Bellete B, Tisseur B . Bicentric evaluation of six anti-toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clin Vaccine Immunol. 2009; 16(9):1322-6. PMC: 2745007. DOI: 10.1128/CVI.00128-09. View

12.

Gay-Andrieu F, Fricker-Hidalgo H, Sickinger E, Espern A, Brenier-Pinchart M, Braun H . Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera. Diagn Microbiol Infect Dis. 2009; 65(3):279-87. DOI: 10.1016/j.diagmicrobio.2009.07.013. View

13.

Yera H, Filisetti D, Bastien P, Ancelle T, Thulliez P, Delhaes L . Multicenter comparative evaluation of five commercial methods for toxoplasma DNA extraction from amniotic fluid. J Clin Microbiol. 2009; 47(12):3881-6. PMC: 2786637. DOI: 10.1128/JCM.01164-09. View

14.

Elbez-Rubinstein A, Ajzenberg D, Darde M, Cohen R, Dumetre A, Yera H . Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review. J Infect Dis. 2008; 199(2):280-5. DOI: 10.1086/595793. View

15.

Bobic B, Klun I, Vujanic M, Nikolic A, Ivovic V, Zivkovic T . Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J Med Microbiol. 2009; 58(Pt 3):358-364. DOI: 10.1099/jmm.0.006668-0. View

16.

Pelloux H, Fricker-Hidalgo H, Brochier G, Goullier-Fleuret A, Ambroise-Thomas P . Intravenous immunoglobulin therapy: confounding effects on serological screening for toxoplasmosis during pregnancy. J Clin Microbiol. 1999; 37(10):3423-4. PMC: 85593. DOI: 10.1128/JCM.37.10.3423-3424.1999. View

17.

Candolfi E, Pastor R, Huber R, Filisetti D, Villard O . IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis. 2007; 58(1):83-8. DOI: 10.1016/j.diagmicrobio.2006.12.010. View

18.

Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun H . Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J Clin Microbiol. 2009; 47(3):603-13. PMC: 2650902. DOI: 10.1128/JCM.01076-08. View

19.

Weiss L, Dubey J . Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009; 39(8):895-901. PMC: 2704023. DOI: 10.1016/j.ijpara.2009.02.004. View

20.

Lefevre-Pettazzoni M, Le Cam S, Wallon M, Peyron F . Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women. Eur J Clin Microbiol Infect Dis. 2006; 25(11):687-93. DOI: 10.1007/s10096-006-0204-1. View